NCT00351078View on ClinicalTrials.gov

PTC124 for the Treatment of Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Cystic Fibrosis

Interventions

DRUG

PTC124

4-,4-, and 8-mg/kg PO first 14 days 10-, 10-, and 20-mg/kg TID second 14 days

Trial Locations (1)

91240

Hadassah University Hospital - Mount Scopus, Jerusalem

Sponsors

Lead Sponsor

PTC Therapeutics

All Listed Sponsors

lead

PTC Therapeutics

INDUSTRY

NCT00351078 - PTC124 for the Treatment of Cystic Fibrosis | Biotech Hunter | Biotech Hunter